Aster DM Healthcare to construct Rs 400 crore hospital in Chennai

KOCHI: Aster DM Healthcare, a leading healthcare service provider in India and in GCC with presence in 9 countries, has entered into an agreement with Subramanya Constructions & Development Company Limited (SCDC), to construct a new hospital in Chennai.

This 500 bedded, multi-specialty hospital is expected to be commissioned in 2020. The total project cost of the hospital is estimated at Rs 400 crore.

Aster DM Healthcare operates 11 hospitals in South India with 4037 installed beds. Commenting on the expansion into the Chennai healthcare market, founder chairman and managing director of Aster DM Healthcare, Azad Moopen said, “Looking at the demand supply gap, there is a requirement for more hospitals in India in general and in Chennai in particular. With our presence in Kerala, Karnataka, Telangana, Andhra and Maharashtra, we believe that our presence in Tamil Nadu would benefit patients in the country. We also see India as a key market for Aster DM Healthcare in future.”

“With our current diversified asset portfolios in Southern and Western India, Tamil Nadu was the only State without our presence. This new flagship hospital due to be commissioned in 2020 will offer state-of-the-art quaternary care services to the people of Tamil Nadu and fulfil the current gap within our network,” said Harish Pillai, CEO, Aster Hospitals & Clinics (India).

Aster DM Healthcare is present in the Middle East, India and the Philippines with a large number of health facilities including 20 hospitals and 98 clinics.

  • Related Posts

    Safdarjung Hospital performs its first dual kidney transplant using organs from marginal donor

    The Indian Air Force airlifted the retrieved organs to Delhi from Command Hospital, Chandimandir, where the 62-year-old donor was declared brain dead. New Delhi: Vardhman Mahavir Medical College (VMMC) and…

    Hospital stocks slide up to 6% after Supreme Court flags drug mark-ups at corporate hospitals

    The court asked the Centre why a 16 per cent retail margin could not apply to all medicines, and will hear the matter again on 12 October. New Delhi: Shares…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore